A Form 4 filed with the SEC on September 11, 2026 discloses that David Tsur, a director of Kamada Ltd (NASDAQ:KMDA), sold Ordinary Shares across three separate transactions between September 7 and September 9, 2026.

Key Highlights

  • Reporting person: David Tsur, identified as a director of Kamada Ltd.
  • First transaction: 14,238 Ordinary Shares sold on September 7, 2026 at $8.28 per share.
  • Second transaction: 162,760 Ordinary Shares sold on September 8, 2026 at $8.26 per share.
  • Third transaction: 175 Ordinary Shares sold on September 9, 2026 at $8.26 per share.
  • Post-transaction holdings: 430,756 Ordinary Shares beneficially owned directly following the final reported transaction.
  • Currency note: All prices are USD convenience conversions from NIS using Bank of Israel exchange rates on each respective transaction date.

Director Share Sales at Kamada Ltd Across Three Consecutive Trading Days

According to the filing, David Tsur, a director of Kamada Ltd, disposed of Ordinary Shares on each of three consecutive days: September 7, 8, and 9, 2026. All three transactions carry transaction code "S," indicating open-market sales, and all disposals are reported as direct ownership. The filing notes that the prices stated in U.S. dollars represent convenience conversions from Israeli new shekels (NIS), using the exchange rate published by the Bank of Israel on each respective transaction date.

Kamada Ltd is an Israeli biopharmaceutical company whose securities trade on NASDAQ under the symbol KMDA, and its Ordinary Shares are priced and traded in a dual-currency context given the company's Israel-based operations. Following the sale of 14,238 shares on September 7, 2026, Tsur held 593,691 Ordinary Shares directly. After the sale of 162,760 shares on September 8, 2026, directly held shares stood at 430,931. The final transaction on September 9, 2026, involving 175 shares, reduced his directly held position to 430,756 Ordinary Shares, the figure reported as his beneficial ownership following all disclosed transactions.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed by one reporting person and was signed by David Tsur on September 11, 2026.

What Was Disclosed

The filing discloses three sales of Ordinary Shares in Kamada Ltd by director David Tsur between September 7 and September 9, 2026, with per-share prices converted from NIS to USD using Bank of Israel rates, and a resulting direct beneficial ownership of 430,756 shares.